Since 1983, PROGEN has been an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. Providing highly validated products to research institutes and universities, pharmaceutical and biotech companies as well as private and clinical laboratories.
While PROGEN ’s antibodies are among the most published antibodies in biomedical and cell biology literature, its ELISA kits aim at niche markets in microbiology, infectious diseases, and immunology. Building on its extensive core-competency and experience in immunochemistry, the company has expanded its product and service portfolio in recent years to include recombinant antibody engineering, antibody phage display technology, density gradient media, and AAV (adeno-associated virus) test kits for gene therapy research.
As a subsidiary of the R-Biopharm Group, PROGEN’s antibodies developed through scientific collaborations are manufactured in Germany and highly validated. PROGEN’s quality management system has been certified to EN ISO 13485:2003 + AC:2007 standard.
Popular product ranges:
- Adeno-Associated Virus (AAV) – a unique range of adeno-associated virus (AAV) antibodies and quantification ELISAs for gene therapy research. Including AAV Titration ELISA kits and AAV ELISA controls for the quantitation of virions and assembled empty capsids of AAV1, AAV2, AAV3, AAV5, AAV6, AAV8 and AAV9.
- Phage Display – antibody hyperphage display technology for the generation of recombinant antibodies, proteins or peptides. Includes antibodies against M13, fd and F1 filamentous phages, Hyperphage M13, Library primer sets and expression vectors.